Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dismantling the Components and Dosing of CBT for Co-Occurring Disorders

NCT02161211 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02161211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02161211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dismantling the Components and Dosing of CBT for Co-Occurring Disorders
Lead sponsor
University of Minnesota
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2014
Completion date
June 19, 2020
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cbt anxiety reduction, cbt combined, cbt decoupling